Relationship between interferon therapy and variability in nonstructural gene 5b of hepatitis C virus

Journal of Gastroenterology

Volumn 33, Issue 5, 1998, Pages 684-693

  Tao, Qimin ^a   Wei, Lai ^a   Chang, Jinhong ^a   Wang, Hao ^a   Sun, Yan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Hepatitis Cc virus; Interferon; Nonstructural gene 5; Quasispecies; Sequence analysis

Indexed keywords

INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; GENE MUTATION; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE;

ADULT; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DNA PRIMERS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0031683453     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050156     Document Type: Article

References (32)

1. Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986;315:1575-1578.
2. Hagiwara H, Hayashi N, Mita E, et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology 1992;15:37-41.
3. Davis GL, Balart LA, Schiff ER, et al. Treatment of hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med 1989;321:1501-1506.
4. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321: 1506-1510.
5. Marcellin P, Boyer N, Giostra E, et al. Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter, randomized controlled trial from France. Hepatology 1991;13:393-397.
6. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993;104:877-883.
7. Yoshioka K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992;16:293-299.
8. Simmons P. Variability of hepatitis C virus. Hepatology 1995;21:570-583.
9. Okamoto H, Mishiro S. Genetic heterogeneity of hepatitis C virus. Intervirology 1994;37:68-76.
10. Kanazawa Y, Hayashi N, Mita E, et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994;20:1121-1130.
11. Koizumi K, Enomoto N, Kurosaki M, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995;22:30-35.
12. Enomoto N, Sakuma I, Asahina Y, et al. Interferon sensitivity determining sequence of the hepatitis C virus genome. J Clin Invest 1995;96:224-230.
13. Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;334:77-81.
14. Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:215-222.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
16. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990;87: 9524-9528.
17. Wang Y, Okmoto H, Tsuda F, et al. Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol 1993;40:254-260.
18. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991;88:2451-2455.
19. Nakao T, Enomoto N, Takada N, et al. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol 1991;72:2105-2112.
20. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-679.
21. Qian L, Wilkinson M. DNA fragment purification: Removal of agarose 10 minutes after electrophoresis. Biotechniques 1991;10:736-738.
22. Okamoto H, Okada S, Sugiyama Y, et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991;72:2697-2704.
23. Weiner AJ, Thaler MM, Crawford K, et al. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 1993;67:4365-4368.
24. Martell M, Esteban JI, Quer J, et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994;68:3425-3436.
25. Kato N, Sekiya H, Ootsuyama Y, et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993;67: 3923-3930.
26. Qu D, Li JS, Vitvitski L, et al. Hepatitis C virus genotypes in France: Comparison of clinical features of patients infected with HCV type I and type II. J Hepatol 1994;21:70-75.
27. Weiner A, Erickson AL, Kansopon J, et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 1995;92:2755-2759.
28. Okada S, Akahane Y, Suzuki H, et al. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992;16:619-624.
29. Battegay M, Fikes J, Di Bisceglie AM, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995;69:2462-2470.
30. Simmonds P, Balfe P, Ludlam CA, et al. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol 1990;64:5840-5850.
31. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 1992;66:3225-3229.
32. Weiner A, Erickson AL, Kansopon J, et al. Persistent hepatitis C virus infection in a chimpanzee in associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 1995;92:2755-2759.